Stage III Merkel Cell Carcinoma AJCC v7
2 clinical trials · Condition
◉ Watch Stage III Merkel Cell Carcinoma AJCC v7
| Record | Firm | Date |
|---|---|---|
| Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors (NCT03074513) | M.D. Anderson Cancer Center | 2017-03-03 |
| Pembrolizumab in Treating Patients With Advanced Merkel Cell Cancer (NCT02267603) | National Cancer Institute (NCI) | 2014-11-25 |
Track Stage III Merkel Cell Carcinoma AJCC v7 automatically
Every clearance here is in the API, with alerts when new ones post.